Metraipolis › archive › dc_aaffbd9e9e7e

Integrated analysis and experimental validation of E2F2 as a potential prognostic biomarker and its oncogenic roles in serous ovarian cancer — Europe PMC PMID:41064634

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41064634
DOI
10.3389/fmolb.2025.1661558
License (as archived)
solo-consultazione
Archived
2026-11-09T19:23:54.873Z
SHA-256 of the archived text
d14614bcc584bb005850cae71c3bdfc2c4ad1a41481f91c4fea2669d6f4a30d5
Stable URL of this page
https://metraipolis.com/documento/dc_aaffbd9e9e7e

How to cite

Integrated analysis and experimental validation of E2F2 as a potential prognostic biomarker and its oncogenic roles in serous ovarian cancer — Europe PMC PMID:41064634 — Europe PMC (en), https://europepmc.org/article/MED/41064634 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aaffbd9e9e7e (Metraipolis archive dc_aaffbd9e9e7e, sha256 d14614bcc584bb005850cae71c3bdfc2c4ad1a41481f91c4fea2669d6f4a30d5)
BibTeX
@misc{dcaaffbd9e9e7e,
  title = {Integrated analysis and experimental validation of E2F2 as a potential prognostic biomarker and its oncogenic roles in serous ovarian cancer — Europe PMC PMID:41064634},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41064634},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aaffbd9e9e7e; sha256 d14614bcc584bb005850cae71c3bdfc2c4ad1a41481f91c4fea2669d6f4a30d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41064634. Agents can read the archived copy with the MCP tool read_document.